IDEAYA Biosciences Announces Board and Executive Changes
Ticker: IDYA · Form: 8-K · Filed: Feb 10, 2025 · CIK: 1676725
| Field | Detail |
|---|---|
| Company | Ideaya Biosciences, Inc. (IDYA) |
| Form Type | 8-K |
| Filed Date | Feb 10, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, compensation
TL;DR
IDEAYA board shakeup and comp changes filed 2/10.
AI Summary
IDEAYA Biosciences, Inc. announced on February 10, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for key personnel.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial priorities.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can indicate internal shifts that may impact future performance or strategic direction.
Key Players & Entities
- IDEAYA Biosciences, Inc. (company) — Registrant
- February 10, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-38915 (filing_id) — Commission File Number
- 47-4268251 (tax_id) — IRS Employer Identification Number
- 5000 Shoreline Court, Suite 300 (address) — Principal executive offices
- South San Francisco, California 94080 (address) — Principal executive offices
- (650) 443-6209 (phone) — Registrant's telephone number
FAQ
What specific items are being reported in this 8-K filing?
This 8-K filing reports on the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements of certain officers.
What is the exact name of the company filing this report?
The exact name of the registrant is IDEAYA Biosciences, Inc.
On what date was this report filed, and what is the earliest event date reported?
The report was filed on February 10, 2025, and the earliest event reported is also February 10, 2025.
In which state was IDEAYA Biosciences, Inc. incorporated?
IDEAYA Biosciences, Inc. was incorporated in Delaware.
What is the principal executive office address for IDEAYA Biosciences, Inc.?
The principal executive office address is 5000 Shoreline Court, Suite 300, South San Francisco, California 94080.
Filing Stats: 643 words · 3 min read · ~2 pages · Grade level 10.6 · Accepted 2025-02-10 06:05:28
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share IDYA The Nasdaq
Filing Documents
- d934896d8k.htm (8-K) — 23KB
- 0001193125-25-023076.txt ( ) — 142KB
- idya-20250210.xsd (EX-101.SCH) — 3KB
- idya-20250210_lab.xml (EX-101.LAB) — 18KB
- idya-20250210_pre.xml (EX-101.PRE) — 11KB
- d934896d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IDEAYA BIOSCIENCES, INC. Date: February 10, 2025 By: /s/ Yujiro Hata Yujiro Hata President and Chief Executive Officer